Table 2.
Best overall response
Confirmed best response | Irinotecan plus cisplatin (n=173) | Etoposide plus cisplatin (n=189) | p-value |
---|---|---|---|
CR | 2 (1.2) | 3 (1.6) | - |
PR | 106 (61.3) | 88 (46.6) | - |
Stable disease | 24 (13.9) | 51 (27.0) | - |
Progressive disease | 4 (2.3) | 18 (9.5) | - |
Not evaluated | 37 (21.4) | 29 (15.3) | - |
Objective response rate (CR+PR) (%) | 62.4 | 48.2 | 0.006a) |
Values are presented as number (%) unless otherwise indicated. CR, complete response; PR, partial response.
Chi-square test.